Voltar
Revisão Acesso aberto Revisado por pares
BIBTEX RIS

The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases

2018; Volume: 4; Issue: 1 Linguagem: Inglês

10.5114/ceh.2018.73155

ISSN

2449-8238

Autores

Kamila Wójcik, Ewa Koślińska-Berkan, Anna Piekarska,

Tópico(s)

Diet, Metabolism, and Disease

Resumo

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Wójcik-Cichy K, Koślińska-Berkan E, Piekarska A. The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases. Clinical and Experimental Hepatology. 2018;4(1):1-6. doi:10.5114/ceh.2018.73155. APA Wójcik-Cichy, K., Koślińska-Berkan, E., & Piekarska, A. (2018). The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases. Clinical and Experimental Hepatology, 4(1), 1-6. https://doi.org/10.5114/ceh.2018.73155 Chicago Wójcik-Cichy, Kamila, Ewa Koślińska-Berkan, and Anna Piekarska. 2018. "The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases". Clinical and Experimental Hepatology 4 (1): 1-6. doi:10.5114/ceh.2018.73155. Harvard Wójcik-Cichy, K., Koślińska-Berkan, E., and Piekarska, A. (2018). The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases. Clinical and Experimental Hepatology, 4(1), pp.1-6. https://doi.org/10.5114/ceh.2018.73155 MLA Wójcik-Cichy, Kamila et al. "The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases." Clinical and Experimental Hepatology, vol. 4, no. 1, 2018, pp. 1-6. doi:10.5114/ceh.2018.73155. Vancouver Wójcik-Cichy K, Koślińska-Berkan E, Piekarska A. The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases. Clinical and Experimental Hepatology. 2018;4(1):1-6. doi:10.5114/ceh.2018.73155.

Referência(s)